Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects

We recently identified acyl coenzyme A-binding protein (ACBP)/diazepam binding inhibitor (DBI) as a novel ‘hunger factor’: a protein that is upregulated in human or murine obesity and that, if administered to mice, causes hyperphagy, adipogenesis and obesity. Conversely, neutralization of ACBP/DBI b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sica, Valentina, Martins, Isabelle, Motiño, Omar, Bravo-San Pedro, José M., Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153538/
https://www.ncbi.nlm.nih.gov/pubmed/32157940
http://dx.doi.org/10.1080/21623945.2020.1736734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153538/
https://www.ncbi.nlm.nih.gov/pubmed/32157940
http://dx.doi.org/10.1080/21623945.2020.1736734

Ejemplares similares